Apellis Pharmaceuticals Inc (APLS)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$25.21

Buy

$26.20

arrow-up$0.265 (+1.06%)

Prices updated at 12 Dec 2025, 22:53 EST

Prices minimum 15 mins delay

Prices in USD

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Jul 2026
Annual general meeting	Jun 2026
Annual report	Feb 2026
Final results	Feb 2026

	Previous date
Half yearly results	Jul 2025
Annual general meeting	Jun 2025
Annual report	Feb 2025
Final results	Feb 2025

Company reports

31 Dec 2023

Annual Report

30 Sep 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.